Paeoniflorin Modulates TREM-1/NF-κB/LXRα/ABCG1 Pathway to Improve Cholesterol Metabolism and Inflammation in Hyperlipidemic Rat
International Journal of Molecular Sciences · 26.03.2026 · 27 (7) · 3039
DOI: 10.3390/ijms27073039 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.03.2026. Verfasst von Ying Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Drugs, Chinese Herbal, Hyperlipidemias, Hypolipidemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TCM Theory Inheritance and Innovation Project of CACMS Innovation Fund, National Natural Science Foundation of China, Fundamental Research Funds for the Central Public Welfare Research Institutes.
Abstract (Originalsprache)
This study aimed to systematically elucidate the antihyperlipidemic mechanism of paeoniflorin, and we adopted an integrated multi-omics strategy to screen the key molecular targets and regulatory pathways involved in its action, followed by experimental validation to verify the potential regulatory effects of paeoniflorin on the screened targets and metabolic processes. Rats with high-fat diet-induced hyperlipidemia received paeoniflorin treatment. Liver histopathology was evaluated using hematoxylin–eosin and Oil Red O staining. Serum levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total bile acids, activated partial thromboplastin time, prothrombin time, thrombin time, and fibrinogen were measured using a biochemical analyzer. Integrated multi-omics analyses were performed to investigate paeoniflorin’s lipid-lowering mechanism. Critical pathways and targets identified were validated using Western blotting. Paeoniflorin alleviated pathological liver damage in hyperlipidemic rats and improved blood lipid levels, coagulation function, and liver function markers. Multi-omics analyses verified that paeoniflorin downregulated the expression of TREM-1, TLR4, NF-κB, TNF-α, and IL-1β, thereby alleviating hepatic inflammation. Paeoniflorin also upregulated the expression of low-density lipoprotein receptors (LDLR), liver X receptor alpha (LXRα), and ATP-binding cassette subfamily G member 1 (ABCG1), while downregulating proprotein convertase subtilisin/kexin type 9 (PCSK9) expression, contributing to balanced cholesterol metabolism. Paeoniflorin normalized glycerophospholipid and branched-chain amino acid metabolism, which correlated with reduced inflammation and improved cholesterol metabolism. Paeoniflorin ameliorates hyperlipidemia through multitarget mechanisms, potentially by suppressing the TREM-1-TLR4-NF-κB signaling pathway to reduce inflammation and by regulating cholesterol metabolism via the PCSK9-LDLR and LXRα-ABCG1 pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
- Experimental Research Centre of China Academy of Chinese Medical Sciences, Beijing 100700, China.
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
- China Association of Chinese Medicine, Beijing 100700, China.
Förderung
- TCM Theory Inheritance and Innovation Project of CACMS Innovation Fund
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Public Welfare Research Institutes
- Beijing High-level Innovative and Entrepreneurial Talents Support Program
- National Natural Science Foundation of China https://ror.org/01h0zpd94
Zitieren
APA
Yang, Y., Li, X., Tang, D. L., Li, B., Wu, S. J., Cao, H. X., Zong, W. J., & Zhang, H. M. (2026). Paeoniflorin Modulates TREM-1/NF-κB/LXRα/ABCG1 Pathway to Improve Cholesterol Metabolism and Inflammation in Hyperlipidemic Rat. International Journal of Molecular Sciences, 27(7), 3039. https://doi.org/10.3390/ijms27073039
Vancouver
Yang Y, Li X, Tang DL, Li B, Wu SJ, Cao HX, et al. Paeoniflorin Modulates TREM-1/NF-κB/LXRα/ABCG1 Pathway to Improve Cholesterol Metabolism and Inflammation in Hyperlipidemic Rat. International Journal of Molecular Sciences. 2026;27(7):3039. doi:10.3390/ijms27073039
BibTeX
@article{Yang2026,
author = {Yang, Ying and Li, Xiang and Tang, Dan-Li and Li, Bing and Wu, Si-Jia and Cao, Hong-Xin and Zong, Wen-Jing and Zhang, Hua-Min},
title = {Paeoniflorin Modulates TREM-1/NF-κB/LXRα/ABCG1 Pathway to Improve Cholesterol Metabolism and Inflammation in Hyperlipidemic Rat},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3039},
doi = {10.3390/ijms27073039}
}
EUVIMED